Cost and Cost-effectiveness of Smear-positive Tuberculosis Treatment by Health Extension Workers in Southern Ethiopia: a Community Randomized Trial

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Feb 23

PMID 20174642

Citations 46

Authors

Daniel G Datiko

Bernt Lindtjorn

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Treatments by HEWs in the health posts and general health workers at health facility were compared along a community-randomized trial. Costs were analysed from societal perspective in 2007 in US $ using standard methods. We prospectively enrolled smear positive patients, and calculated cost-effectiveness as the cost per patient successfully treated. The total cost for each successfully treated smear-positive patient was higher in health facility ($158.9) compared with community ($61.7). Community-based treatment reduced the total, patient and caregiver cost by 61.2%, 68.1% and 79.8%, respectively. Involving HEWs added a total cost of $8.80 (14.3% of total cost) on health service per patient treated in the community.

Conclusions/significance: Community-based treatment by HEWs costs only 39% of what treatment by general health workers costs for similar outcomes. Involving HEWs in TB treatment is a cost effective treatment alternative to the health service, to the patients and the family. There is an economic and public health reason to consider involving HEWs in TB treatment in Ethiopia. However, community-based treatment requires initial investment to start its implementation, training and supervision.

Trial Registration: ClinicalTrials.gov NCT00803322.

Citing Articles

Incidence and determinants of households' catastrophic payments for TB care: evidence from a multi-country trial (EXIT-TB project) implemented in East Africa.

Ngadaya F, Philbert D, Wilfred A, Mshiu J, Binyaruka P, Mnyambwa N BMJ Public Health. 2025; 3(1):e001543.

PMID: 40017933 PMC: 11843488. DOI: 10.1136/bmjph-2024-001543.

Determinants of an unfavorable treatment outcome among tuberculosis patients in the Jimma Zone, Southwest Ethiopia.

Ereso B, Sagbakken M, Gradmann C, Yimer S Sci Rep. 2024; 14(1):29281.

PMID: 39592639 PMC: 11599842. DOI: 10.1038/s41598-024-78084-0.

Effectiveness and cost-effectiveness of community-based directly observed treatment (DOT) versus health facility-based DOT of tuberculosis in Africa: protocol for a systematic review and meta-analysis.

Baye T, Kassaw A, Gebrie D, Girmaw F, Ashagrie G BMJ Open. 2024; 14(5):e081767.

PMID: 38724061 PMC: 11086473. DOI: 10.1136/bmjopen-2023-081767.

Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis.

Assefa D, Dememew Z, Zeleke E, Manyazewal T, Bedru A BMC Public Health. 2024; 24(1):260.

PMID: 38254019 PMC: 10804496. DOI: 10.1186/s12889-024-17713-9.

Economic evaluation of a community health worker model for tuberculosis care in Ho Chi Minh City, Viet Nam: a mixed-methods Social Return on Investment Analysis.

Vo L, Forse R, Tran J, Dam T, Driscoll J, Codlin A BMC Public Health. 2023; 23(1):945.

PMID: 37231468 PMC: 10210363. DOI: 10.1186/s12889-023-15841-2.

References

Kangangi J, Kibuga D, Muli J, Maher D, Billo N, Nganga L . Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos district, Kenya. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S5-13. View

Murray C, Kreuser J, Whang W . Cost-effectiveness analysis and policy choices: investing in health systems. Bull World Health Organ. 1994; 72(4):663-74. PMC: 2486597. View

Yassin M, Datiko D, Shargie E . Ten-year experiences of the tuberculosis control programme in the southern region of Ethiopia. Int J Tuberc Lung Dis. 2006; 10(10):1166-71. View

Singh A, Parasher D, Shekhavat G, Sahu S, Wares D, Granich R . Effectiveness of urban community volunteers in directly observed treatment of tuberculosis patients: a field report from Haryana, North India. Int J Tuberc Lung Dis. 2004; 8(6):800-2. View

Wandwalo E, Kapalata N, Egwaga S, Morkve O . Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis. 2004; 8(10):1248-54. View

Baltussen R, Floyd K, Dye C . Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005; 331(7529):1364. PMC: 1309642. DOI: 10.1136/bmj.38645.660093.68. View

Dye C, Garnett G, Sleeman K, Williams B . Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet. 1998; 352(9144):1886-91. DOI: 10.1016/s0140-6736(98)03199-7. View

Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D . Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S56-62. View

Maher D, Harries A, Getahun H . Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health. 2005; 10(8):734-42. DOI: 10.1111/j.1365-3156.2005.01456.x. View

10.

Mangura B, Napolitano E, Passannante M, Sarrel M, McDonald R, Galanowsky K . Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis. Int J Tuberc Lung Dis. 2002; 6(8):654-61. View

11.

Briggs A, Gray A . Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999; 3(2):1-134. View

12.

Maher D, Hausler H, Raviglione M, Kaleeba N, Aisu T, Fourie B . Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis. 1997; 1(3):276-83. View

13.

Obermeyer Z, Abbott-Klafter J, Murray C . Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS One. 2008; 3(3):e1721. PMC: 2253827. DOI: 10.1371/journal.pone.0001721. View

14.

Wandwalo E, Robberstad B, Morkve O . Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Eff Resour Alloc. 2005; 3:6. PMC: 1180840. DOI: 10.1186/1478-7547-3-6. View

15.

Okello D, Floyd K, Adatu F, Odeke R, Gargioni G . Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S72-9. View

16.

Nganda B, Wangombe J, Floyd K, Kangangi J . Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S14-20. View

17.

Nyirenda T, Harries A, Gausi F, van Gorkom J, Maher D, Floyd K . Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S21-8. View

18.

Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F . Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S29-37. View

19.

Datiko D, Yassin M, Chekol L, Kabeto L, Lindtjorn B . The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health. 2008; 8:266. PMC: 2542368. DOI: 10.1186/1471-2458-8-266. View

20.

Datiko D, Lindtjorn B . Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009; 4(5):e5443. PMC: 2678194. DOI: 10.1371/journal.pone.0005443. View